oxybutynin has been researched along with Pelvic Floor Diseases in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dengler, KL | 1 |
| High, RA | 1 |
| Moga, DC | 1 |
| Zillioux, J | 1 |
| Wagg, A | 1 |
| DuBeau, CE | 1 |
| Ackenbom, MF | 1 |
| Alperin, M | 1 |
| Dumoulin, C | 1 |
| Birder, LA | 1 |
| Mazloomdoost, D | 1 |
| Lai, HH | 1 |
| Sung, VW | 1 |
| Gray, SL | 1 |
| Sanses, TVD | 1 |
1 review available for oxybutynin and Pelvic Floor Diseases
| Article | Year |
|---|---|
Overactive Bladder and Cognitive Impairment: The American Urogynecologic Society and Pelvic Floor Disorders Research Foundation State-of-the-Science Conference Summary Report.
Topics: Aged; Cholinergic Antagonists; Cognitive Dysfunction; Female; Humans; Mechanotransduction, Cellular; | 2023 |